GO:0003707 nuclear steroid receptor activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0003707 (nuclear steroid receptor activity) describes a nuclear receptor activity that is regulated by steroid binding and that modulates transcription of specific gene sets transcribed by RNA polymerase II.
• Steroid hormone receptors such as ESR1, AR, NR3C1, PGR and others act as ligand-regulated transcription factors and are the canonical carriers of this activity.
• Coactivators (e.g., NCOA1/SRC-1, NCOA2, NCOA3) and corepressors (e.g., NCOR1, NCOR2) are essential modifiers of nuclear steroid receptor transcriptional output.
• Extra-nuclear and cytoplasmic steroid receptor signaling interfaces with nuclear receptor activity and contributes to hormone-dependent cancer biology.
• Dysregulation of nuclear steroid receptor activity is central to breast, prostate, endometrial and other endocrine-related cancers and to immune and neuroendocrine processes.
• CRISPR knockout, point-mutation, knock-in and overexpression models enable causal dissection of receptor and cofactor function in this pathway.
Description
GO:0003707, nuclear steroid receptor activity, is a molecular function ontology term describing a nuclear receptor activity that is regulated by steroid binding and that modulates transcription of specific gene sets transcribed by RNA polymerase II. Steroid hormone receptors are ligand-activated transcription factors that convert endocrine signals into changes in gene expression programs, and they are prototypical members of the nuclear receptor superfamily. Because this activity sits at the interface of hormone physiology, immunity, brain function and cancer, it is a major focus of molecular endocrinology and drug discovery. Researchers study GO:0003707 to understand how steroid ligands, receptor proteins, coactivators and corepressors cooperate to control RNA polymerase II transcribed gene sets. The activity is not confined to the nucleus; extra-nuclear and cytoplasmic steroid receptor signaling can influence and intersect with nuclear receptor actions, adding layers of regulation relevant to hormone-dependent cancers. In this article we synthesize the QuickGO definition with verified PubMed literature to describe the mechanism, key genes, disease links and experimental methods associated with nuclear steroid receptor activity.
nuclear steroid receptor activity At A Glance
| GO ID | GO:0003707 |
|---|---|
| GO term | nuclear steroid receptor activity |
| Ontology | molecular_function |
| Synonym | steroid hormone receptor activity |
| Definition | A nuclear receptor activity regulated by steroid binding and modulating the transcription of specific gene sets transcribed by RNA polymerase II. |
| Major function | Ligand-regulated transcription factor activity that controls RNA polymerase II transcribed gene sets. |
| Representative receptors | ESR1, ESR2, AR, PGR, NR3C1, NR3C2, VDR, THRA, THRB, RARA, RARB, RARG. |
| Key cofactors | NCOA1, NCOA2, NCOA3, NCOR1, NCOR2. |
| Disease relevance | Breast cancer, prostate cancer, endometrial cancer, immune regulation, neuroendocrine and behavioral processes. |
What Is GO:0003707?
In our own words, GO:0003707 (nuclear steroid receptor activity) is a molecular function in which a nuclear receptor protein binds a steroid ligand and, as a consequence, regulates transcription of specific gene sets that are transcribed by RNA polymerase II. It is the steroid-regulated subclass of nuclear receptor activity, and its synonym is steroid hormone receptor activity. The activity requires the receptor to act in the nucleus on target gene promoters or enhancers, often with coactivator or corepressor complexes, to modulate RNA polymerase II dependent transcription.
Why Is nuclear steroid receptor activity Important in Cell Biology?
Nuclear steroid receptor activity is important because it is the molecular mechanism through which steroid hormones such as estrogens, androgens, progestins and glucocorticoids reprogram gene expression, and because its dysregulation underlies major human diseases including hormone-dependent cancers and immune and neuroendocrine disorders. Understanding GO:0003707 helps researchers interpret how endocrine signals are converted into transcriptional outputs and how coactivator and corepressor complexes shape those outputs.
• Defines the steroid-regulated branch of nuclear receptor activity that controls RNA polymerase II transcribed gene sets.
• Explains how estrogens, androgens, progestins and glucocorticoids reprogram gene expression.
• Provides a mechanistic basis for hormone-dependent cancers such as breast and prostate cancer.
• Highlights the role of coactivators (NCOA1/2/3) in amplifying steroid receptor transcriptional output.
• Highlights the role of corepressors (NCOR1/NCOR2) in restraining antagonist-occupied steroid receptors.
• Connects nuclear receptor activity to extra-nuclear and cytoplasmic steroid signaling interfaces.
• Relevant to immunity through steroid receptor coactivator function in immune cells.
• Relevant to brain function and behavior through nuclear receptor coactivators.
• Relevant to endocrine-related tissues and cancer through interplay with FGF signaling.
• Supports development of endocrine therapies and CRISPR-based functional models.
What Happens During nuclear steroid receptor activity?
Ligand binding and receptor activation
In simple terms: A steroid hormone docks onto its receptor, switching the receptor into an active state.
Nuclear steroid receptor activity begins when a steroid ligand binds its cognate nuclear receptor, converting the receptor into a transcriptionally active form. This ligand-regulated step is the defining feature of GO:0003707, distinguishing it from other nuclear receptor activities. Steroid receptor signaling is not exclusively nuclear; extra-nuclear and cytoplasmic pools of steroid receptors can also signal and interface with nuclear actions.
DNA binding and target gene recognition
In simple terms: The activated receptor finds specific DNA regions and attaches to them.
Once activated, steroid receptors bind specific DNA response elements to modulate transcription of specific gene sets transcribed by RNA polymerase II. This DNA-binding step positions the receptor to regulate target promoters and enhancers. The specificity of target gene sets is a core property of nuclear steroid receptor activity.
Coactivator recruitment and transcriptional activation
In simple terms: Helper proteins are recruited to boost gene transcription.
Steroid/nuclear receptor coactivators are recruited by activated receptors and are essential for efficient transcriptional activation. Nuclear receptor coactivators such as NCOA1, NCOA2 and NCOA3 act as essential players for steroid hormone action in the brain and in behavior. Steroid receptor coactivators also play roles in immunity, illustrating the broad physiological reach of this activity.
Corepressor modulation and antagonist effects
In simple terms: Other helper proteins can dampen or block transcription, especially when antagonists are bound.
A nuclear receptor corepressor can modulate the transcriptional activity of antagonist-occupied steroid hormone receptors, providing a mechanism for negative regulation of this activity. Corepressor recruitment therefore shapes the net transcriptional output of steroid receptors. This balance between coactivators and corepressors is central to the regulation of nuclear steroid receptor activity.
Integration with extra-nuclear and growth factor signaling
In simple terms: Signals from outside the nucleus and from growth factors can tune the receptor's activity.
The interface of nuclear and membrane steroid signaling shows that extra-nuclear pathways can influence nuclear steroid receptor activity. Nuclear actions of FGF members in endocrine-related tissues and cancer can also interplay with steroid receptor pathways. These intersections expand the regulatory context in which GO:0003707 operates.
Key Genes Involved in GO:0003707 nuclear steroid receptor activity
The following genes encode receptors and cofactors that carry out or modulate nuclear steroid receptor activity (GO:0003707).
| Gene | Major Role | Research Relevance |
|---|---|---|
| ESR1 | Estrogen receptor alpha, steroid-regulated transcription factor | Breast cancer and endocrine therapy research |
| ESR2 | Estrogen receptor beta, steroid-regulated transcription factor | Estrogen signaling and endocrine-related cancer research |
| AR | Androgen receptor, steroid-regulated transcription factor | Prostate cancer and androgen signaling research |
| PGR | Progesterone receptor, steroid-regulated transcription factor | Breast and endometrial biology research |
| NR3C1 | Glucocorticoid receptor, steroid-regulated transcription factor | Stress, immune and metabolic research |
| NR3C2 | Mineralocorticoid receptor, steroid-regulated transcription factor | Electrolyte and endocrine research |
| VDR | Vitamin D receptor, steroid-regulated transcription factor | Calcium and endocrine-related tissue research |
| THRA | Thyroid hormone receptor alpha, nuclear receptor | Steroid-thyroid hormone nuclear receptor superfamily physiology |
| THRB | Thyroid hormone receptor beta, nuclear receptor | Steroid-thyroid hormone nuclear receptor superfamily physiology |
| RARA | Retinoic acid receptor alpha, nuclear receptor | Nuclear receptor superfamily research |
| RARB | Retinoic acid receptor beta, nuclear receptor | Nuclear receptor superfamily research |
| RARG | Retinoic acid receptor gamma, nuclear receptor | Nuclear receptor superfamily research |
| NCOA1 | Steroid receptor coactivator 1 (SRC-1) | Coactivator function in steroid hormone action |
| NCOA2 | Steroid receptor coactivator 2 (SRC-2) | Coactivator function in steroid hormone action |
| NCOA3 | Steroid receptor coactivator 3 (SRC-3) | Coactivator function in steroid hormone action |
| NCOR1 | Nuclear receptor corepressor 1 | Corepressor modulation of antagonist-occupied receptors |
| NCOR2 | Nuclear receptor corepressor 2 | Corepressor modulation of steroid receptor transcription |
How Is nuclear steroid receptor activity Regulated?
Nuclear steroid receptor activity is regulated at multiple levels. Ligand binding is the primary switch, converting the receptor into a transcriptionally active state that modulates RNA polymerase II transcribed gene sets. Coactivator recruitment amplifies transcriptional output, and steroid/nuclear receptor coactivators are essential for efficient steroid hormone action. Conversely, corepressors can modulate the transcriptional activity of antagonist-occupied steroid hormone receptors, providing negative regulation. Extra-nuclear and cytoplasmic steroid receptor signaling can also interface with and influence nuclear receptor activity. In addition, nuclear actions of FGF members in endocrine-related tissues and cancer can interplay with steroid receptor pathways, adding growth factor inputs to this regulation.
nuclear steroid receptor activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ESR1 | Breast cancer and endocrine therapy | CRISPR knockout or point-mutation in breast cancer cell lines |
| AR | Prostate cancer and androgen signaling | CRISPR knockout or knock-in in prostate cancer cell lines |
| PGR | Breast and endometrial biology | CRISPR knockout in endometrial or breast cell lines |
| NR3C1 | Immune and stress-related biology | CRISPR knockout in immune cell models |
| NCOA1/NCOA2/NCOA3 | Coactivator-driven steroid hormone action | CRISPR knockout or overexpression in endocrine and immune cells |
Hormone-dependent cancers
Extra-nuclear and cytoplasmic steroid receptor signaling is implicated in hormone-dependent cancers, and nuclear steroid receptor activity is central to their biology. Breast and prostate cancers are classic examples where steroid receptors such as ESR1 and AR drive transcriptional programs. Interplay between FGF signaling and steroid receptor pathways in endocrine-related tissues and cancer further links this activity to tumor biology.
Immune regulation
Steroid receptor coactivators, which are essential modifiers of nuclear steroid receptor activity, play roles in immunity. This connects GO:0003707 to immune cell function and inflammatory processes. Glucocorticoid receptor signaling is a well-known steroid receptor pathway relevant to immune regulation.
Brain function and behavior
Nuclear receptor coactivators are essential players for steroid hormone action in the brain and in behavior. This links nuclear steroid receptor activity to neuroendocrine and behavioral processes. The steroid-thyroid hormone nuclear receptor superfamily also has broad physiological roles relevant to neural and endocrine function.
Endocrine-related tissue biology
Nuclear actions of FGF members in endocrine-related tissues and cancer interplay with steroid receptor pathways, indicating that GO:0003707 is embedded in broader endocrine signaling networks. The physiology of the steroid-thyroid hormone nuclear receptor superfamily underscores the wide physiological importance of this activity.
From nuclear steroid receptor activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does the receptor gene drive steroid-regulated transcription? | CRISPR knockout cell model |
| Does a specific receptor mutation alter ligand response? | CRISPR point-mutation knock-in model |
| How does a tagged receptor behave in live cells? | Tagged knock-in model |
| Does coactivator overexpression amplify transcriptional output? | CRISPR overexpression model |
| Does corepressor loss change antagonist response? | CRISPR knockout of NCOR1/NCOR2 |
| How do extra-nuclear and nuclear pathways interact? | CRISPR models combined with signaling assays |
How to Study the nuclear steroid receptor activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Changes in RNA polymerase II transcribed gene sets | Measuring transcriptional output of steroid receptors |
| Reporter assay | Ligand-regulated transcriptional activity | Testing receptor activation and antagonists |
| Coactivator interaction assay | Recruitment of NCOA1/2/3 | Studying coactivator function |
| Corepressor interaction assay | Recruitment of NCOR1/NCOR2 | Studying antagonist-occupied receptor modulation |
| Imaging | Subcellular localization of steroid receptors | Distinguishing nuclear and extra-nuclear pools |
| CRISPR knockout | Loss-of-function effects on this activity | Causal gene testing |
| CRISPR knock-in | Effects of specific mutations or tags | Allele-specific functional studies |
| CRISPR overexpression | Gain-of-function effects | Testing coactivator amplification |
Transcriptional readouts (RNA-seq, reporter assays)
Because nuclear steroid receptor activity modulates transcription of specific gene sets transcribed by RNA polymerase II, RNA-seq and reporter assays are core methods to measure its output. These approaches quantify changes in target gene expression after ligand treatment or receptor perturbation. They are widely used in endocrine-related cancer research.
Coactivator and corepressor interaction assays
Coactivator and corepressor recruitment is central to nuclear steroid receptor activity, so interaction assays are used to study these complexes. Such assays help define how coactivators amplify and corepressors dampen transcriptional output. They are relevant to immunity and brain function studies of steroid receptor coactivators.
Imaging and subcellular localization
The interface of nuclear and membrane steroid signaling means that subcellular localization matters for this activity. Imaging approaches can distinguish nuclear versus extra-nuclear and cytoplasmic steroid receptor pools. These methods help link localization to function in hormone-dependent cancers.
CRISPR-based functional genomics
CRISPR knockout, point-mutation, knock-in and overexpression models allow causal testing of receptor and cofactor genes in this pathway. Functional genomics screens can identify modifiers of nuclear steroid receptor activity. These models complement biochemical and transcriptional assays.
How CRISPR Can Be Used to Study GO:0003707 nuclear steroid receptor activity
Knockout
CRISPR knockout of steroid receptor genes or cofactor genes (e.g., NCOA1/2/3, NCOR1/2) can test their requirement for nuclear steroid receptor activity and downstream transcription. Knockout models are useful for causal dissection of hormone-dependent cancer biology. They also help define corepressor-dependent modulation of antagonist-occupied receptors.
Point Mutation
CRISPR point mutation can introduce specific amino acid changes to test how receptor mutations alter ligand response and transcriptional output. Such models are valuable for studying resistance or altered specificity in endocrine-related cancers. They allow precise structure-function interrogation of this activity.
Knock-in
CRISPR knock-in can add tags or reporter sequences to receptor or cofactor genes to track localization and interactions. Tagged knock-in models help study nuclear versus extra-nuclear steroid receptor pools. They also support studies of coactivator and corepressor dynamics.
Overexpression
CRISPR overexpression can elevate receptor or coactivator levels to test gain-of-function effects on nuclear steroid receptor activity. Overexpression of steroid receptor coactivators can amplify transcriptional output in endocrine and immune contexts. These models complement knockout studies for bidirectional functional analysis.
How EDITGENE Supports nuclear steroid receptor activity Research
Researchers studying nuclear steroid receptor activity-related genes often need to determine whether a candidate gene is causally involved in ligand-regulated transcription, coactivator recruitment or corepressor modulation, and CRISPR-based cell models provide a direct way to test these hypotheses.
Contact EDITGENE today to design your custom CRISPR model for nuclear steroid receptor activity research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| Ppard Knockout NIT-1 Cell Line | EDJ-KQ60 | Mouse | 19015 | Details Get a Quote |
| PPARD Knockout HEK293 Cell Line | EDJ-KQ115 | Human | 5467 | Details Get a Quote |
| RXRA Knockout HEK293 Cell Line | EDJ-KQ864 | Human | 6256 | Details Get a Quote |
| PPARA Knockout HEK293 Cell Line | EDJ-KQ1808 | Human | 5465 | Details Get a Quote |
| HNF4A Knockout HEK293 Cell Line | EDJ-KQ1865 | Human | 3172 | Details Get a Quote |
| NR1D1 Knockout HEK293 Cell Line | EDJ-KQ2307 | Human | 9572 | Details Get a Quote |
| NR2E1 Knockout HEK293 Cell Line | EDJ-KQ2438 | Human | 7101 | Details Get a Quote |
| VDR Knockout HEK293 Cell Line | EDJ-KQ2441 | Human | 7421 | Details Get a Quote |
| ESR2 Knockout HEK293 Cell Line | EDJ-KQ2775 | Human | 2100 | Details Get a Quote |
| PGR Knockout HEK293 Cell Line | EDJ-KQ3386 | Human | 5241 | Details Get a Quote |
| PAQR7 Knockout HEK293 Cell Line | EDJ-KQ3403 | Human | 164091 | Details Get a Quote |
| ESRRA Knockout HEK293 Cell Line | EDJ-KQ4554 | Human | 2101 | Details Get a Quote |
| ESRRG Knockout HEK293 Cell Line | EDJ-KQ4557 | Human | 2104 | Details Get a Quote |
| ESRRB Knockout HEK293 Cell Line | EDJ-KQ4561 | Human | 2103 | Details Get a Quote |
| NR3C2 Knockout HEK293 Cell Line | EDJ-KQ5218 | Human | 4306 | Details Get a Quote |
Displaying Records 1 To 15 Of 116 Records
- 1
- 2
- Next Page »
Frequently Asked Questions About nuclear steroid receptor activity
What is GO:0003707 nuclear steroid receptor activity?
GO:0003707 is a molecular function term describing a nuclear receptor activity regulated by steroid binding that modulates transcription of specific gene sets transcribed by RNA polymerase II.
What genes are involved in nuclear steroid receptor activity?
Key genes include ESR1, ESR2, AR, PGR, NR3C1, NR3C2, VDR, THRA, THRB, RARA, RARB, RARG and cofactors such as NCOA1, NCOA2, NCOA3, NCOR1 and NCOR2.
What is the synonym of GO:0003707?
The synonym is steroid hormone receptor activity.
How is nuclear steroid receptor activity regulated?
It is regulated by steroid ligand binding, coactivator recruitment and corepressor modulation, with additional input from extra-nuclear and growth factor signaling.
Which diseases are linked to nuclear steroid receptor activity?
It is linked to hormone-dependent cancers such as breast and prostate cancer, as well as immune and neuroendocrine processes.
What are steroid receptor coactivators?
Steroid receptor coactivators such as NCOA1, NCOA2 and NCOA3 are proteins recruited by activated receptors that are essential for efficient steroid hormone action.
How do corepressors affect steroid receptor activity?
A nuclear receptor corepressor can modulate the transcriptional activity of antagonist-occupied steroid hormone receptors.
Can CRISPR be used to study nuclear steroid receptor activity?
Yes, CRISPR knockout, point-mutation, knock-in and overexpression models can test receptor and cofactor function in this pathway.
What methods measure nuclear steroid receptor activity?
RNA-seq, reporter assays, coactivator and corepressor interaction assays, imaging and CRISPR-based functional genomics are commonly used.
Why is nuclear steroid receptor activity important in cancer?
It drives transcriptional programs in hormone-dependent cancers and interfaces with extra-nuclear and growth factor signaling pathways.
Conclusion
GO:0003707 nuclear steroid receptor activity defines the steroid-regulated nuclear receptor function that modulates RNA polymerase II transcribed gene sets, and it is carried out by receptors such as ESR1, AR, PGR and NR3C1 together with coactivators and corepressors. Its dysregulation is central to hormone-dependent cancers and to immune and neuroendocrine biology, making it a high-value target for mechanistic and translational research. CRISPR-based knockout, point-mutation, knock-in and overexpression models provide powerful tools to dissect this activity and its disease relevance.
References
- 1. Agbana S et al.. 2024. Extra-nuclear and cytoplasmic steroid receptor signalling in hormone dependent cancers.. J Steroid Biochem Mol Biol 243:106559 PMID: 38823459
- 2. Chen JD. 2000. Steroid/nuclear receptor coactivators.. Vitam Horm 58:391-448 PMID: 10668406
- 3. Zhang X et al.. 1998. A nuclear receptor corepressor modulates transcriptional activity of antagonist-occupied steroid hormone receptor.. Mol Endocrinol 12(4):513-24 PMID: 9544987
- 4. Gilad Y et al.. 2022. Steroid receptor coactivators - their role in immunity.. Front Immunol 13:1079011 PMID: 36582250
- 5. Williams GR et al.. 1994. Physiology of the steroid-thyroid hormone nuclear receptor superfamily.. Baillieres Clin Endocrinol Metab 8(2):241-66 PMID: 8092972
- 6. Tetel MJ. 2009. Nuclear receptor coactivators: essential players for steroid hormone action in the brain and in behaviour.. J Neuroendocrinol 21(4):229-37 PMID: 19207820
- 7. Treviño LS et al.. 2021. The Interface of Nuclear and Membrane Steroid Signaling.. Endocrinology 162(8) PMID: 34038515
- 8. Figueroa V et al.. 2019. Nuclear action of FGF members in endocrine-related tissues and cancer: Interplay with steroid receptor pathways.. Steroids 152:108492 PMID: 31513818
